exogenous fructose metabolism insulin independent fructose insulin-independent fuel source vivo conversion theoretical limitation clinical usefulness diabetics large doses small amounts fructose setting insulinopenia low-dose fructose infusion g/hr fasting type diabetic patient continuous subcutaneous insulin dose stable euglycemia hr plasma glucose mg/dl low infusion rate calorie requirement immediate marked rise plasma glucose mg/dl hr Glucose loss urine accumulation plasma half hexose load utilization small quantities exogenous fructose impaired hypoinsulinemic conditions insulin-independent fuel source 